Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Amazon
AMZN
|
+$307M |
| 2 |
Walmart
WMT
|
+$213M |
| 3 |
Verizon
VZ
|
+$201M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$175M |
| 5 |
Home Depot
HD
|
+$171M |
Top Sells
| 1 |
Charter Communications
CHTR
|
+$277M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$241M |
| 3 |
SYKE
SYKES Enterprises Inc
SYKE
|
+$165M |
| 4 |
Huntington Bancshares
HBAN
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$144M |
Sector Composition
| 1 | Financials | 17.76% |
| 2 | Technology | 16.31% |
| 3 | Industrials | 12.61% |
| 4 | Consumer Discretionary | 11.38% |
| 5 | Healthcare | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Transmedics
TMDX
$3.91B
| $12.5M | ﹤0.01% |
376,662
-19,520
| -5% | -$646K |
|
2227
Gildan
GIL
$8.03B
| $12.5M | ﹤0.01% |
341,081
+159,379
| +88% | +$5.82M |
|
|
SWTX
2228
DELISTED
SpringWorks Therapeutics
SWTX
| $12.4M | ﹤0.01% |
195,836
+120,323
| +159% | +$7.63M |
|
2229
ANI Pharmaceuticals
ANIP
$2.12B
| $12.4M | ﹤0.01% |
378,216
-60,960
| -14% | -$2M |
|
2230
Syndax Pharmaceuticals
SNDX
$1.34B
| $12.4M | ﹤0.01% |
648,026
+146,228
| +29% | +$2.79M |
|
2231
Palomar
PLMR
$3.13B
| $12.4M | ﹤0.01% |
153,179
+875
| +0.6% | +$70.7K |
|
2232
Camping World
CWH
$1.04B
| $12.3M | ﹤0.01% |
317,134
+172,131
| +119% | +$6.69M |
|
2233
Core Laboratories
CLB
$581M
| $12.3M | ﹤0.01% |
443,121
-306,977
| -41% | -$8.52M |
|
|
AUD
2234
DELISTED
Audacy, Inc.
AUD
| $12.3M | ﹤0.01% |
3,334,326
-330,870
| -9% | -$1.22M |
|
2235
RB Global
RBA
$21.7B
| $12.2M | ﹤0.01% |
197,848
+17,885
| +10% | +$1.1M |
|
|
MCBC
2236
DELISTED
Macatawa Bank Corp
MCBC
| $12.2M | ﹤0.01% |
1,517,862
-45,943
| -3% | -$369K |
|
2237
Tandem Diabetes Care
TNDM
$829M
| $12.2M | ﹤0.01% |
102,070
-35,191
| -26% | -$4.2M |
|
2238
Kura Oncology
KURA
$711M
| $12.2M | ﹤0.01% |
650,241
-110,066
| -14% | -$2.06M |
|
2239
Dimensional US Core Equity Market ETF
DFAU
$9.23B
| $12.2M | ﹤0.01% |
404,000
| – | – |
|
|
VRAY
2240
DELISTED
ViewRay, Inc.
VRAY
| $12.2M | ﹤0.01% |
1,688,463
+322,318
| +24% | +$2.32M |
|
|
KG
2241
Kestrel Group, Ltd.
KG
$211M
| $12.2M | ﹤0.01% |
192,461
-2,462
| -1% | -$156K |
|
2242
RBB Bancorp
RBB
$332M
| $12.2M | ﹤0.01% |
482,047
+17,415
| +4% | +$439K |
|
2243
GoPro
GPRO
$327M
| $12.1M | ﹤0.01% |
1,297,412
+207,446
| +19% | +$1.94M |
|
2244
NL Industries
NL
$295M
| $12.1M | ﹤0.01% |
2,101,593
-57,754
| -3% | -$333K |
|
2245
Tenaris
TS
$18.7B
| $12.1M | ﹤0.01% |
572,464
+102,385
| +22% | +$2.16M |
|
2246
Orion Group Holdings
ORN
$299M
| $12.1M | ﹤0.01% |
2,217,569
-81,177
| -4% | -$442K |
|
2247
Tidewater
TDW
$2.93B
| $12.1M | ﹤0.01% |
999,361
-132,880
| -12% | -$1.6M |
|
2248
Weyco Group
WEYS
$280M
| $12M | ﹤0.01% |
530,456
-13,004
| -2% | -$295K |
|
2249
BCB Bancorp
BCBP
$148M
| $12M | ﹤0.01% |
813,569
+5,572
| +0.7% | +$82.2K |
|
2250
Boston Omaha
BOC
$425M
| $12M | ﹤0.01% |
308,604
+57,621
| +23% | +$2.23M |
|